Adial Pharmaceuticals ADIL Stock
2.56 USD
{{ price }}
-1.915710%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
9.45M USD
LOW - HIGH [24H]
2.29
-
2.87 USD
VOLUME [24H]
2.75M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.91 USD
Adial Pharmaceuticals Price Chart
Adial Pharmaceuticals ADIL Financial and Trading Overview
| Adial Pharmaceuticals stock price | 2.56 USD |
| Previous Close | 0.23 USD |
| Open | 0.23 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 0.22 - 0.26 USD |
| 52 Week Range | 0.2 - 2.08 USD |
| Volume | 69.93K USD |
| Avg. Volume | 202.64K USD |
| Market Cap | 7.04M USD |
| Beta (5Y Monthly) | 0.953504 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 USD |
ADIL Valuation Measures
| Enterprise Value | 4.44M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.74242425 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.9 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.337 |
Trading Information
Adial Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.953504 |
| 52-Week Change | -80.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.08 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.3 USD |
| 200-Day Moving Average | 0.34 USD |
ADIL Share Statistics
| Avg. Volume (3 month) | 202.64K USD |
| Avg. Daily Volume (10-Days) | 98.37K USD |
| Shares Outstanding | 28.72M |
| Float | 23.82M |
| Short Ratio | 0.77 |
| % Held by Insiders | 13.61% |
| % Held by Institutions | 5.74% |
| Shares Short | 93.24K |
| Short % of Float | 0.36% |
| Short % of Shares Outstanding | 0.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -92.21% |
| Return on Equity (ttm) | -209.58% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -13170611 USD |
| Net Income Avi to Common (ttm) | -12729413 USD |
| Diluted EPS (ttm) | -0.43 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.31M USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 193.8K USD |
| Total Debt/Equity (mrq) | 13.46 USD |
| Current Ratio (mrq) | 1.649 |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10988045 USD |
| Levered Free Cash Flow (ttm) | -6081591 USD |
Profile of Adial Pharmaceuticals
| Country | United States |
| State | VA |
| City | Charlottesville |
| Address | 1180 Seminole Trail |
| ZIP | 22901 |
| Phone | 434-422-9800 |
| Website | https://www.adialpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Q&A For Adial Pharmaceuticals Stock
What is a current ADIL stock price?
Adial Pharmaceuticals ADIL stock price today per share is 2.56 USD.
How to purchase Adial Pharmaceuticals stock?
You can buy ADIL shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adial Pharmaceuticals?
The stock symbol or ticker of Adial Pharmaceuticals is ADIL.
Which industry does the Adial Pharmaceuticals company belong to?
The Adial Pharmaceuticals industry is Biotechnology.
How many shares does Adial Pharmaceuticals have in circulation?
The max supply of Adial Pharmaceuticals shares is 3.69M.
What is Adial Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Adial Pharmaceuticals PE Ratio is now.
What was Adial Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Adial Pharmaceuticals EPS is -4.91 USD over the trailing 12 months.
Which sector does the Adial Pharmaceuticals company belong to?
The Adial Pharmaceuticals sector is Healthcare.
Adial Pharmaceuticals ADIL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}